Compare CHKP & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHKP | STE |
|---|---|---|
| Founded | 1993 | 1985 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 25.9B |
| IPO Year | 1996 | 1992 |
| Metric | CHKP | STE |
|---|---|---|
| Price | $192.22 | $263.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 9 |
| Target Price | $230.95 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 958.3K | 674.3K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | 24.68 | ★ 59.39 |
| EPS | ★ 9.12 | 6.97 |
| Revenue | $2,684,200,000.00 | ★ $5,702,415,000.00 |
| Revenue This Year | $8.42 | $9.24 |
| Revenue Next Year | $6.01 | $6.30 |
| P/E Ratio | ★ $21.17 | $37.72 |
| Revenue Growth | 6.31 | ★ 7.08 |
| 52 Week Low | $178.64 | $200.98 |
| 52 Week High | $234.36 | $268.60 |
| Indicator | CHKP | STE |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 59.06 |
| Support Level | $180.72 | $256.68 |
| Resistance Level | $188.00 | $268.60 |
| Average True Range (ATR) | 5.63 | 4.64 |
| MACD | 0.72 | -0.69 |
| Stochastic Oscillator | 63.24 | 65.59 |
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.